These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 19000892)

  • 1. [Correction of anemia in renal insufficiency: what target?].
    Drüeke TB
    Nephrol Ther; 2008 Oct; 4 Spec No 2():1-8. PubMed ID: 19000892
    [No Abstract]   [Full Text] [Related]  

  • 2. [Change of hemoglobin level: causes and consequences. Renal anemia].
    Ryckelynck JP
    Nephrol Ther; 2008 Oct; 4 Spec No 2():9-16. PubMed ID: 19000893
    [No Abstract]   [Full Text] [Related]  

  • 3. Target hemoglobin level for EPO therapy in CKD.
    Parfrey PS
    Am J Kidney Dis; 2006 Jan; 47(1):171-3. PubMed ID: 16377399
    [No Abstract]   [Full Text] [Related]  

  • 4. Anemia in renal insufficiency.
    Santoro A
    Rev Clin Exp Hematol; 2002; Suppl 1():12-20. PubMed ID: 12735211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The target hemoglobin in patients with chronic kidney disease.
    Singh AK
    Nephrol News Issues; 2006 Dec; 20(13):29-30. PubMed ID: 17168056
    [No Abstract]   [Full Text] [Related]  

  • 6. Correction of anemia--payoffs and problems.
    Remuzzi G; Ingelfinger JR
    N Engl J Med; 2006 Nov; 355(20):2144-6. PubMed ID: 17108347
    [No Abstract]   [Full Text] [Related]  

  • 7. Critical appraisal of randomized controlled trials of anemia correction in patients with renal failure.
    Parfrey PS
    Curr Opin Nephrol Hypertens; 2011 Mar; 20(2):177-81. PubMed ID: 21157336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Managing anemia. What do we do now? Views from Canada.
    Mendelssohn DC; Muirhead N; Manns BJ
    Nephrol News Issues; 2007 Jun; 21(7):55-7. PubMed ID: 17623988
    [No Abstract]   [Full Text] [Related]  

  • 9. [What are the aims and targets of renal anemia therapy?].
    Eckardt KU
    Dtsch Med Wochenschr; 2007 Sep; 132(36):1837-41. PubMed ID: 17726657
    [No Abstract]   [Full Text] [Related]  

  • 10. [Update on the management of anemia. Nephrology World Congress 2009].
    Verhelst D
    Nephrol Ther; 2010 Jun; 6(3 Suppl):1-9. PubMed ID: 20538247
    [No Abstract]   [Full Text] [Related]  

  • 11. Epoetin beta once weekly: review of its efficacy and safety in patients with chemotherapy-induced anemia.
    Spaëth D
    Expert Rev Anticancer Ther; 2008 Jun; 8(6):875-85. PubMed ID: 18533797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemoglobin levels, quality of life, and survival.
    Sadler JH; Meyer KB
    Nephrol News Issues; 2007 Aug; 21(9):42-3. PubMed ID: 17722853
    [No Abstract]   [Full Text] [Related]  

  • 13. Can evidence drive the development of a sound national EPO reimbursement policy?
    Wish JB
    Am J Kidney Dis; 2003 Jan; 41(1):254-8. PubMed ID: 12500246
    [No Abstract]   [Full Text] [Related]  

  • 14. [Chronic lymphatic leukemia: significance of erythropoietin].
    Barthel HR
    Dtsch Med Wochenschr; 2002 May; 127(18):982; author reply 982-3. PubMed ID: 11987022
    [No Abstract]   [Full Text] [Related]  

  • 15. KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for anemia in chronic kidney disease: 2007 update of hemoglobin target.
    KDOQI
    Am J Kidney Dis; 2007 Sep; 50(3):471-530. PubMed ID: 17720528
    [No Abstract]   [Full Text] [Related]  

  • 16. [New preparations of erythropoietin].
    Sakaguchi T; Akizawa T
    Nihon Rinsho; 2004 May; 62 Suppl 5():360-3. PubMed ID: 15197945
    [No Abstract]   [Full Text] [Related]  

  • 17. Blind Pew sends a black spot: the current haemoglobin controversy.
    Stevens PE
    Blood Purif; 2008; 26(1):54-8. PubMed ID: 18182797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. III. Clinical practice recommendations for anemia in chronic kidney disease in children.
    ;
    Am J Kidney Dis; 2006 May; 47(5 Suppl 3):S86-108. PubMed ID: 16678669
    [No Abstract]   [Full Text] [Related]  

  • 19. Erythropoietin treatment for ischemic cardiomyopathy: anemia correction and myocardial protection.
    Ben-Dor I; Battler A
    Timely Top Med Cardiovasc Dis; 2007 Dec; 11():E33. PubMed ID: 18301786
    [No Abstract]   [Full Text] [Related]  

  • 20. Mortality risk in dialysis patients with naturally higher hemoglobins.
    Harford AM; Zager PG
    J Am Soc Nephrol; 2011 Feb; 22(2):205-6. PubMed ID: 21289211
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.